On Oct. 29, Pfizer PFE announced third-quarter results, beating estimates for earnings as well as sales. Revenues rose 32% on ...

Social Security is likely to deliver less income than you expect. But you can make up the difference and more via ...

Pfizer has a well-diversified pipeline, with several late-stage assets to drive medium-term growth. Learn more about PFE ...

Pfizer, J&J, Biogen and Novartis are banking on new products to make up for maturing blockbusters, but future growth is not ...

At Shionogi, a Japanese pharmaceutical company, executives pointed out that COVID is still flaring in Japan. In Japan, ...

In parallel, the Court of Justice will hear details of a second case next month — the “Pfizergate” legal battle over access to alleged text messages between von der Leyen and Pfizer CEO Albert Bourla ...

In life, there’s a common expression that also carries over into the dividend investing world: If it seems too good to be true, it usually is ...

It’s just another earnings week in the life of pharmaceutical CEOs, with blockbuster expectations running up against cruel ...

Amidst a share value slump and executive turmoil, Pfizer reported a robust quarter thanks in part to Covid-19 drug sales.

(Reuters) -Pfizer CEO Albert Bourla, under pressure from activist hedge fund Starboard Value, made his case to Wall Street on ...

With a market cap of $161.3 billion, New York-based Pfizer Inc. (PFE) is a leading global biopharmaceutical company. Known ...

(Operator Instructions) Good day, everyone, and welcome to Pfizer's third-quarter 2024 earnings conference call. Today's call is being recorded. At this time, I would like to turn the call over to ...